Marketing in drug development phase is quite different to “marketing” in the general sense of the word.
Very involved at all key stakeholder levels and a lot more strategic in planning, exactly what is needed here at RAC to map out the correct path.
“Global & US lead, working within our ultra rare disease product/portfolio eg. "Leniolisib". A matrix leadership position with the accountability to collaboratively lead the commercial & clinical teams to execute a successful go to market strategy & registration process across multiple affiliates”
Understand you want stone evidence in the form of an announcement because you can’t analyse the opportunity very well, usually buying when the risk has been removed means your paying multiple’s compared to what you could have, each to their own.
General Comments / Chat, page-8036
-
- There are more pages in this discussion • 3,846 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.59 |
Change
0.010(0.63%) |
Mkt cap ! $270.9M |
Open | High | Low | Value | Volume |
$1.60 | $1.60 | $1.56 | $168.3K | 106.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 51 | $1.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 54981 | 1.550 |
1 | 700 | 1.520 |
1 | 2750 | 1.510 |
3 | 7984 | 1.505 |
5 | 17550 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.600 | 20000 | 1 |
1.620 | 2000 | 1 |
1.685 | 5000 | 1 |
1.690 | 6570 | 3 |
1.695 | 7731 | 1 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |